|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Soerjomataram I, Lortet-Tieulent J, Parkin
DM, Ferlay J, Mathers C, Forman D and Bray F: Global burden of
cancer in 2008: A systematic analysis of disability-adjusted
life-years in 12 world regions. Lancet. 380:1840–1850. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tan P and Yeoh KG: Genetics and molecular
pathogenesis of gastric adenocarcinoma. Gastroenterology.
149:1153–1162.e3. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu CJ, Prazak L, Fajardo M, Yu S, Tyagi N
and Di Cesare PE: Leukemia/lymphoma-related factor, a POZ
domain-containing transcriptional repressor, interacts with histone
deacetylase-1 and inhibits cartilage oligomeric matrix protein gene
expression and chondrogenesis. J Biol Chem. 279:47081–47091. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pessler F, Pendergrast PS and Hernandez N:
Purification and characterization of FBI-1, a cellular factor that
binds to the human immunodeficiency virus type 1 inducer of short
transcripts. Mol Cell Biol. 17:3786–3798. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kukita A, Kukita T, Ouchida M, Maeda H,
Yatsuki H and Kohashi O: Osteoclast-derived zinc finger (OCZF)
protein with POZ domain, a possible transcriptional repressor, is
involved in osteoclastogenesis. Blood. 94:1987–1997.
1999.PubMed/NCBI
|
|
9
|
Davies JM, Hawe N, Kabarowski J, Huang QH,
Zhu J, Brand NJ, Leprince D, Dhordain P, Cook M, Morriss-Kay G and
Zelent A: Novel BTB/POZ domain zinc-finger protein, LRF, is a
potential target of the LAZ-3/BCL-6 oncogene. Oncogene. 18:365–375.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Apostolopoulou K, Pateras IS, Evangelou K,
Tsantoulis PK, Liontos M, Kittas C, Tiniakos DG, Kotsinas A,
Cordon-Cardo C and Gorgoulis VG: Gene amplification is a relatively
frequent event leading to ZBTB7A (Pokemon) overexpression in
non-small cell lung cancer. J Pathol. 213:294–302. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maeda T, Hobbs RM, Merghoub T, Guernah I,
Zelent A, Cordon-Cardo C, Teruya-Feldstein J and Pandolfi PP: Role
of the proto-oncogene Pokemon in cellular transformation and ARF
repression. Nature. 433:278–285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Costoya JA: Functional analysis of the
role of POK transcriptional repressors. Brief Funct Genomic
Proteomic. 6:8–18. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang L, Siu MK, Wong OG, Tam KF, Lam EW,
Ngan HY, Le XF, Wong ES, Chan HY and Cheung AN: Overexpression of
proto-oncogene FBI-1 activates membrane type 1-matrix
metalloproteinase in association with adverse outcome in ovarian
cancers. Mol Cancer. 9:3182010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aggarwal A, Hunter WJ III, Aggarwal H,
Silva ED, Davey MS, Murphy RF and Agrawal DK: Expression of
leukemia/lymphoma-related factor (LRF/POKEMON) in human breast
carcinoma and other cancers. Exp Mol Pathol. 89:140–148. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qu H, Qu D, Chen F, Zhang Z, Liu B and Liu
H: ZBTB7 overexpression contributes to malignancy in breast cancer.
Cancer Invest. 28:672–678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vredeveld LC, Rowland BD, Douma S,
Bernards R and Peeper DS: Functional identification of LRF as an
oncogene that bypasses RASV12-induced senescence via upregulation
of CYCLIN E. Carcinogenesis. 31:201–207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao ZH, Wang SF, Yu L, Wang J, Chang H,
Yan WL, Zhang J and Fu K: Overexpression of Pokemon in non-small
cell lung cancer and foreshowing tumor biological behavior as well
as clinical results. Lung Cancer. 62:113–119. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Beroukhim R, Mermel CH, Porter D, Wei G,
Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J,
Urashima M, et al: The landscape of somatic copy-number alteration
across human cancers. Nature. 463:899–905. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zack TI, Schumacher SE, Carter SL,
Cherniack AD, Saksena G, Tabak B, Lawrence MS, Zhsng CZ, Wala J,
Mermel CH, et al: Pan-cancer patterns of somatic copy number
alteration. Nat Genet. 45:1134–1140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu XS, Genet MD, Haines JE, Mehanna EK,
Wu S, Chen HI, Chen Y, Qureshi AA, Han J, Chen X, et al: ZBTB7A
Suppresses melanoma metastasis by transcriptionally repressing
MCAM. Mol Cancer Res. 13:1206–1217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang G, Lunardi A, Zhang J, Chen Z, Ala U,
Webster KA, Tay Y, Gonzalez-Billalabeitia E, Egia A, Shaffer DR, et
al: Zbtb7a suppresses prostate cancer through repression of a
Sox9-dependent pathway for cellular senescence bypass and tumor
invasion. Nat Genet. 45:739–746. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu XS, Haines JE, Mehanna EK, Genet MD,
Ben-Sahra I, Asara JM, Manning BD and Yuan ZM: ZBTB7A acts as a
tumor suppressor through the transcriptional repression of
glycolysis. Genes Dev. 28:1917–1928. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shi DB, Wang YW, Xing AY, Gao JW, Zhang H,
Guo XY and Gao P: C/EBPα-induced miR-100 expression suppresses
tumor metastasis and growth by targeting ZBTB7A in gastric cancer.
Cancer Lett. 369:376–385. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bengtsson M, Hemberg M, Rorsman P and
Ståhlberg A: Quantification of mRNA in single cells and modelling
of RT-qPCR induced noise. BMC Mol Biol. 9:632008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kubista M, Andrade JM, Bengtsson M,
Forootan A, Jonák J, Lind K, Sindelka R, Sjöback R, Sjögreen B,
Strömbom L, et al: The real-time polymerase chain reaction. Mol
Aspects Med. 27:95–125. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang SM, Tie J, Wang WL, Hu SJ, Yin JP, Yi
XF, Tian ZH, Zhang XY, Li MB, Li ZS, et al: POU2F2-oriented network
promotes human gastric cancer metastasis. Gut. 65:1427–1438. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang ZY and Ge HY: Micrometastasis in
gastric cancer. Cancer Lett. 336:34–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Garraway LA and Lander ES: Lessons from
the cancer genome. Cell. 153:17–37. 2013. View Article : Google Scholar : PubMed/NCBI
|
